Patents by Inventor Katalin Mikecz

Katalin Mikecz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220218806
    Abstract: The invention relates to peptide heteroconjugates useful in treating Rheumatoid Arthritis (RA). The peptide heteroconjugates include a portion of the Human aggrecan protein conjugated to an Immune Cell Binding Ligand (ICBL) by a direct bond or divalent linker. The peptide heteroconjugates including combinations thereof, can be used as a vaccination for RA when combined with an adjuvant and administered to a subject.
    Type: Application
    Filed: May 11, 2019
    Publication date: July 14, 2022
    Applicant: CRL-SCI Corporation
    Inventors: Daniel H. Zimmerman, Tibor T Glant, Katalin MIKECZ, Roy E Carambula
  • Publication number: 20160158330
    Abstract: The invention is related to peptide constructs, i.e.
    Type: Application
    Filed: April 28, 2014
    Publication date: June 9, 2016
    Applicant: Cel-Sci Corporation
    Inventors: Daniel H. Zimmerman, Roy Carambula, Harold Steiner, Eyal Talor, Tibor Glant, Katalin Mikecz
  • Patent number: 6001356
    Abstract: The present invention provides a method for preventing tissue destruction associated with autoimmune inflammatory diseases by utilizing anti-CD44 monoclonal antibodies to induce the loss of the CD44 receptor from cell surfaces, thus preventing the interaction between cell-surface CD44 and extracellular hyaluronan.
    Type: Grant
    Filed: September 26, 1996
    Date of Patent: December 14, 1999
    Assignee: Rush-Presbyterian-St. Luke's Medical Center
    Inventors: Katalin Mikecz, Tibor Tivadar Glant